UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback